Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
CHOLESTASIS
NewsCommon virus may play a role in ICP development, study finds
Infection with human cytomegalovirus (HCMV), a common and usually harmless virus, may play a role in the development of…
FATTY LIVER DISEASE
NewsLower-cost TAEUS device tracks liver fat on par with gold standard
TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard…
CHOLANGITIS
NewsNebokitug reduces immune cell activity that drives PSC: Data
Nebokitug, an experimental infusion therapy being developed by Chemomab Therapeutics for primary sclerosing…
FATTY LIVER DISEASE
NewsBelapectin may help reduce liver scarring in those with severe MASH
Galectin Therapeutics‘ experimental medication belapectin may help reduce liver scarring, or fibrosis, and lower the risk of blood vessel…
BILIARY ATRESIA
NewsStem cell therapy may boost liver health in infants with biliary atresia
Therapy using stem cells derived from donor umbilical cords may help improve outcomes in infants with biliary atresia who…
New modeling data predict that bemnifosbuvir and ruzasvir, an experimental combination treatment being developed by Atea Pharmaceuticals for…
CHOLESTASIS
NewsMelatonin may protect the liver from cholestasis-related injury
Treatment with melatonin, a naturally occurring hormone best known for regulating sleep, may help reduce liver injury caused by…
FATTY LIVER DISEASE
NewsRezdiffra reduces liver scarring in high-risk MASH patients: Trial data
Long-term treatment with Rezdiffra (resmetirom) reduces liver scarring and other signs of advanced disease in adults with high-risk compensated cirrhosis…
FATTY LIVER DISEASE
NewsNew drug HU6 cuts liver fat but preserves muscle mass
HU6, an experimental oral therapy from Rivus Pharmaceuticals, safely and effectively reduced liver fat and led to fat-selective weight…